Canton Hathaway LLC trimmed its position in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 37.5% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 10,000 shares of the technology company’s stock after selling 6,000 shares during the period. Canton Hathaway LLC’s holdings in Simulations Plus were worth $395,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in the business. Conestoga Capital Advisors LLC lifted its position in shares of Simulations Plus by 126.9% during the second quarter. Conestoga Capital Advisors LLC now owns 1,640,595 shares of the technology company’s stock valued at $90,085,000 after buying an additional 917,610 shares during the last quarter. Neuberger Berman Group LLC lifted its position in shares of Simulations Plus by 12.6% during the second quarter. Neuberger Berman Group LLC now owns 1,373,988 shares of the technology company’s stock valued at $75,446,000 after buying an additional 153,825 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Simulations Plus by 1.9% during the second quarter. Vanguard Group Inc. now owns 1,010,822 shares of the technology company’s stock valued at $55,505,000 after acquiring an additional 18,772 shares in the last quarter. Ranger Investment Management L.P. increased its holdings in shares of Simulations Plus by 21.8% during the second quarter. Ranger Investment Management L.P. now owns 794,127 shares of the technology company’s stock valued at $43,606,000 after acquiring an additional 142,355 shares in the last quarter. Finally, State Street Corp increased its holdings in shares of Simulations Plus by 6.4% during the second quarter. State Street Corp now owns 521,349 shares of the technology company’s stock valued at $28,627,000 after acquiring an additional 31,537 shares in the last quarter. 70.85% of the stock is owned by institutional investors and hedge funds.
Shares of NASDAQ SLP traded down $1.03 during midday trading on Thursday, reaching $51.04. 121,161 shares of the stock were exchanged, compared to its average volume of 172,017. The company has a market capitalization of $1.03 billion, a price-to-earnings ratio of 110.96, a price-to-earnings-growth ratio of 7.51 and a beta of 0.07. Simulations Plus, Inc. has a twelve month low of $36.90 and a twelve month high of $90.92. The firm has a 50-day moving average price of $46.00.
The company also recently disclosed a quarterly dividend, which was paid on Monday, November 1st. Stockholders of record on Monday, October 25th were paid a dividend of $0.06 per share. The ex-dividend date of this dividend was Friday, October 22nd. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.47%. Simulations Plus’s payout ratio is 52.17%.
Several equities analysts have recently issued reports on the stock. Craig Hallum upgraded shares of Simulations Plus from a “hold” rating to a “buy” rating and cut their price objective for the company from $65.00 to $53.00 in a report on Tuesday, October 26th. TheStreet downgraded shares of Simulations Plus from a “b-” rating to a “c+” rating in a report on Monday, August 2nd. Finally, Zacks Investment Research downgraded shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Friday, October 29th. One investment analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Buy” and an average price target of $64.50.
In other news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Wednesday, October 27th. The stock was sold at an average price of $45.32, for a total transaction of $906,400.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Walter S. Woltosz sold 8,803 shares of the firm’s stock in a transaction on Monday, August 30th. The shares were sold at an average price of $44.90, for a total value of $395,254.70. The disclosure for this sale can be found here. Insiders have sold a total of 58,503 shares of company stock worth $2,505,754 in the last ninety days. Corporate insiders own 23.24% of the company’s stock.
Simulations Plus Company Profile
Simulations Plus, Inc provides modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. It operates through the following segments: Simulations Plus, Inc, Cognigen Corporation, DILIsym, and Lixoft. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students.
Recommended Story: How to interpret the current ratio
Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP).
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.